Ensign Operating Income Over Time
| ENSG Stock | USD 173.18 0.42 0.24% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Ensign Performance and Ensign Correlation. Can Health Care Providers & Services industry sustain growth momentum? Does Ensign have expansion opportunities? Factors like these will boost the valuation of Ensign. Projected growth potential of Ensign fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Ensign demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth 0.06 | Dividend Share 0.25 | Earnings Share 5.58 | Revenue Per Share | Quarterly Revenue Growth 0.198 |
Investors evaluate Ensign Group using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Ensign's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Ensign's market price to deviate significantly from intrinsic value.
It's important to distinguish between Ensign's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ensign should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Ensign's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Operating Income Analysis
Compare Ensign Group and related stocks such as Encompass Health Corp, Solventum Corp, and Revvity Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EHC | (1.7 M) | 374.1 M | 413.4 M | 458.8 M | 465.7 M | 554.2 M | 648.8 M | 649.4 M | 681.6 M | 692.5 M | 661.9 M | 659.4 M | 630.2 M | 1.7 B | 864.5 M | 994.2 M | 693.4 M |
| SOLV | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.9 B | 1.7 B | 1.7 B | 1 B | 932.4 M | 1.2 B |
| RVTY | 63.9 M | 117.9 M | 200.8 M | 258.8 M | 230.5 M | 266.8 M | 305.7 M | 304.6 M | 371 M | 405.5 M | 1 B | 1.3 B | 781.1 M | 399.5 M | 410.5 M | 356.6 M | 268.7 M |
| ALGN | (14.7 M) | 90.4 M | 85.6 M | 94.2 M | 193.6 M | 188.6 M | 248.9 M | 353.6 M | 466.6 M | 542.5 M | 387.2 M | 976.4 M | 642.6 M | 643.3 M | 607.6 M | 698.8 M | 733.7 M |
| DVA | 17.2 M | 1.2 B | 1.3 B | 1.6 B | 1.8 B | 1.1 B | 2 B | 1.8 B | 1.5 B | 1.6 B | 1.7 B | 1.8 B | 1.3 B | 1.6 B | 2.1 B | 2 B | 1.1 B |
| QGEN | 4.7 M | 99.6 M | 169.8 M | 63.3 M | 161.7 M | 179.5 M | 98.8 M | 153.4 M | 266.6 M | (26.1 M) | 386.4 M | 630.1 M | 531.5 M | 409.9 M | 97.7 M | 112.4 M | 159.9 M |
| UHS | 67.9 M | 897.1 M | 942.6 M | 1 B | 1.1 B | 1.3 B | 1.3 B | 1.3 B | 1.2 B | 1.2 B | 1.4 B | 1.4 B | 1 B | 1.2 B | 1.7 B | 1.9 B | 2 B |
| EXEL | (15.3 M) | 89.5 M | (122.4 M) | (200.7 M) | (224.5 M) | (121.4 M) | (28.1 M) | 165.9 M | 438.9 M | 369.5 M | 110.1 M | 286.7 M | 201.5 M | 170.9 M | 604.6 M | 695.3 M | 730.1 M |
| BMRN | (12.9 M) | (33.9 M) | (110.2 M) | (156 M) | (92.9 M) | (110.7 M) | (803.4 M) | (14.7 M) | (123.5 M) | (100.5 M) | (43.4 M) | (82.3 M) | 161 M | 185.8 M | 484.2 M | 556.8 M | 584.7 M |
| ELAN | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 283.2 M | 142.4 M | 313.8 M | 370 M | (76.8 M) | 304 M | 384 M | 326 M | 251 M | 288.6 M | 253.3 M |
Ensign Group and related stocks such as Encompass Health Corp, Solventum Corp, and Revvity Operating Income description
Operating Income is the amount of profit realized from Ensign Group operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of The Ensign Group is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| The Ensign Group | ENSG |
| Classification | Obamacare |
| Business Address | 29222 Rancho Viejo |
| Exchange | NASDAQ Exchange |
USD 173.18
Check out Ensign Performance and Ensign Correlation. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Ensign technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.